Roundup: HealthPlix launches drug-drug interaction feature, Intellect partners with Swiss Life and more briefs

Preview

来源: mobihealthnews

Credit: HealthPlix

Indian EMR platform HealthPlix launches drug-drug interaction feature

Indian EMR startup HealthPlix Technologies has gone live with a new drug-to-drug interaction feature on its platform.

The new tool on the HealthPlix EMR is said to reduce the time taken in writing prescriptions by assisting doctors in recalling molecule-to-molecule interactions at the point of care.

Before, doctors have to rely on external platforms to check drug-to-drug interactions, which prolongs the prescription process.

"In addition to prescribing medicine based on diagnosis, DDI provides suggestions for drugs that may be relevant to the treatment course," added Dr Peyush Khera, a consultant cardiologist using the HealthPlix EMR.

The feature comes with a reference interactions library that helps doctors identify potentially unsafe combinations of medications.

HealthPlix plans to grow this library by integrating with global third-party providers. It targets to expand its database from 4L to 10L by March next year.

The new drug-to-drug interactions feature follows the release of the doctor insights and patient summary dashboards on the EMR app.

Mental health startup Intellect partners with global insurer Swiss Life Network

Intellect, a mental health tech company in Singapore, is partnering with global insurance company Swiss Life Network to co-develop employee benefits solutions for Asian employers.

Intellect has a mental health benefits solution for employers featuring self-guided content as well as telehealth services that connect users to licensed coaches and clinical therapists.

"Through this partnership, we look forward to co-creating employee wellbeing solutions and improving access to comprehensive mental healthcare and wellbeing support across Asia," said Jonathan Cuevas, commercial head of Intellect.

US-based healthcare cloud services provider Healthcare Triangle expands to APAC

Healthcare Triangle, a California-based provider of healthcare cloud transformation services and data analytics platforms, has started expanding to the Asia-Pacific region by opening its regional headquarters in Singapore.

Healthcare Triangle is HITRUST-certified and a partner of Amazon Web Services, Google Cloud, and Microsoft Azure to provide multi-cloud services. It also offers proprietary digital health solutions such as the cloud-as-a-service platform CloudEz, data analytics platform DataEz, and medical document automation tool readabl.ai.

The cloud services provider is tapping into the APAC digital health market, which is projected to grow to $326.7 billion in value by 2030 from $40.3 billion last year.

"The APAC regional headquarters will be based out of Singapore, an encouraging and supportive place for global businesses. At Healthcare Triangle, innovation and attention to technology are foremost, and this ethos aligns with Singapore’s smart nation drive," said Healthcare Triangle chairman and CEO Suresh Venkatachari.

According to a press statement, the company is expected to invest up to $25 million in Singapore and create more than 500 jobs over the next five years.

It also plans to partner with the Shankar Group, a diversified enterprise in consumer goods, property development, and services, to expand its presence across South Asia, the Middle East, Japan, and Australia.

Tags: HealthPlix, India, EMR, drug-to-drug interaction, Intellect, Singapore, Swiss Life Network, employee benefits, mental health, Healthcare Triangle, healthcare cloud, data analytics

更多内容，请访问原始网站

文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。